Clinical Trial Update: Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing docetaxel plus gemcitabine versus gemcitabine alone in elderly patients with non-small cell lung cancer has been terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Non-small-cell Lung Cancer | Phase 3 | Status: TERMINATED